2024/10/18 22:00:00 | |
---|---|
Price | |
54.10 USD | |
Difference | -1.31% (-0.72) |
ISIN | US60770K1079 |
Symbol | MRNA |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 19,204 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 54.10 USD (200) |
Ask (Ask size) | 54.30 USD (200) |
Open | 54.535 USD |
High | 55.10 USD |
Low | 53.55 USD |
Close (prev. day) | 54.82 USD |
VWAP | 54.105546 USD |
Volume (pcs) | 6,754,694 |
Trading volume | 365,421,542.38 |
Number of trades | 82,141 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 22:00:00 | |
---|---|
Price | |
54.10 USD | |
Difference | -1.31% (-0.72) |
ISIN | US60770K1079 |
Symbol | MRNA |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 19,204 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 54.10 USD (200) |
Ask (Ask size) | 54.30 USD (200) |
Open | 54.535 USD |
High | 55.10 USD |
Low | 53.55 USD |
Close (prev. day) | 54.82 USD |
VWAP | 54.105546 USD |
Volume (pcs) | 6,754,694 |
Trading volume | 365,421,542.38 |
Number of trades | 82,141 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -46.96% | -37.10% | -83.84% |
Perf (abs.) | -47.90 | -31.91 | -280.74 |
Beta | 1.62 | 1.57 | 1.34 |
Volatility | 65.27 | 60.48 | 64.47 |
Ø price 5 days | Ø volume 5 days (pcs.) | 56.28 USD (4,577,051) |
Ø price 30 days | Ø volume 30 days (pcs.) | 64.24 USD (5,894,308) |
Ø price 100 days | Ø volume 100 days (pcs.) | 97.98 USD (4,479,558) |
Ø price 250 days | Ø volume 250 days (pcs.) | 98.66 USD (4,466,683) |
YTD High | date | 170.47 USD (2024/05/24) |
YTD Low | date | 53.55 USD (2024/10/18) |
52 Weeks High | date | 170.47 USD (2024/05/24) |
52 Weeks Low | date | 53.55 USD (2024/10/18) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/10/18 | 21:48 | 49.895 EUR | 0.09 | 19 |
Duesseldorf | 2024/10/18 | 19:30 | 49.685 EUR | 0.01 | 6 |
Euronext Milan MTF Global Equity Market | 2024/10/18 | 17:44 | 49.585 EUR | 0.21 | 87 |
Euronext Milan MTF Trading After Hours | 2024/10/14 | 19:03 | 52.94 EUR | 0.00 | 1 |
Frankfurt | 2024/10/18 | 17:39 | 49.885 EUR | 0.03 | 13 |
Hamburg | 2024/10/18 | 21:22 | 49.585 EUR | 0.08 | 9 |
Hanover | 2024/10/18 | 17:25 | 49.58 EUR | 0.00 | 4 |
London Stock Exchange European Trade Reporting | 2024/10/18 | 17:30 | 54.18 USD | 0.00 | 15 |
Munich | 2024/10/18 | 16:14 | 49.90 EUR | 0.00 | 2 |
Nasdaq | 2024/10/18 | 22:00 | 54.10 USD | 365.42 | 82,141 |
Stuttgart | 2024/10/18 | 21:35 | 49.77 EUR | 0.09 | 20 |
Tradegate | 2024/10/18 | 22:26 | 49.81 EUR | 1.28 | 253 |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 49.64 EUR | 0.04 | 13 |
Xetra | 2024/10/18 | 17:35 | 49.795 EUR | 0.42 | 145 |
MODERNA INC. |
- - |
325 Binney Street - 02142 Cambridge |
Telefon: +1-617-714-6500 |
Fax: + |
E-mail: info@modernatx.com |
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. |
Noubar Afeyan | Chairman of Board of Directors |
Elizabeth Nabel | Member of Board of Directors |
Francois Nader | Member of Board of Directors |
Sandra Horning | Member of Board of Directors |
David Rubenstein | Member of Board of Directors |
Elizabeth Tallett | Member of Board of Directors |
Paul Sagan | Member of Board of Directors |
Shah Hussain | Member of Board of Directors |
Stéphane Bancel | Chairman of Managing Board |
Brad Miller | Member of Executive Committee |
Jamey Mock | Member of Executive Committee |
Jerh Collins | Member of Executive Committee |
Kate Cronin | Member of Executive Committee |
Shannon Thyme Klinger | Member of Executive Committee |
Stephen Hoge | Member of Executive Committee |
Tracey Franklin | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer